Results 11 to 20 of about 24,839 (303)
Clinicopathological analysis of histological variants of ameloblastoma in a suburban Nigerian population [PDF]
, 2006 BACKGROUND: This study was carried out to establish the relative incidence and provide clinico-pathologic information on the various histological types of ameloblastoma seen at the Obafemi Awolowo University Teaching Hospital complex, Ile-Ife in order to
Kehinde E. Adebiyi +4 more
openalex +5 more sources
Clinicopathologic Profile, Management and Outcome of Sinonasal Ameloblastoma—A Systematic Review
Journal of Clinical Medicine, 2023 Sinonasal ameloblastoma (SNA) is considered to be a subtype of ameloblastoma. It differs from gnathic ameloblastoma in terms of clinicopathologic features, management and prognosis. Thus, the objective of the present review was to study the complications,
Vini Mehta +6 more
semanticscholar +1 more source
CHARACTERISTIC OF AMELOBLASTOMA IN ORAL AND MAXILLOFACIAL SURGERY AT HASAN SADIKIN HOSPITAL : 2 YEARS RETROSPECTIVE STUDY [PDF]
, 2021 Background: Ameloblastoma is the most common odontogenic tumor. Ameloblastoma is a borderline tumor because it is a benign but locally aggressive tumor with a high recurrence rate if the excision is not complete.
Sylvyana, Melita +2 more
core +2 more sources
Ameloblastoma: An Updated Narrative Review of an Enigmatic Tumor
Cureus, 2022 Ameloblastoma is one of the most common benign odontogenic tumors of the jaw that constitutes about 10% of all tumors that arise in the mandible and maxilla.
S. Ghai
semanticscholar +1 more source
Medical Oncology, 2023 Background Ameloblastoma in 66% of the cases harbor a somatic mutation of the “mitogen-activated protein kinase” signaling pathway (BRAF V600E). In V600E mutations, BRAF is in the permanent “on” state and relays the growth-promoting signals independently
M. Ebeling +5 more
semanticscholar +1 more source
Case Report: A Rare Location of Recurrent Ameloblastoma. [PDF]
Clin Case RepABSTRACT This case report contributes to understanding the complexities of ameloblastoma recurrence despite meeting recommended guidelines and highlights the importance of long‐term follow‐up and tailored surgical approaches.
Yech-Chou M +6 more
europepmc +2 more sources
BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis
Cancers, 2022 Simple Summary Ameloblastoma is a benign odontogenic tumour, and the patient always presents at a later stage when the tumour is already in an aggressive state.
Mohd Nazzary Mamat Yusof +2 more
semanticscholar +1 more source
Head &Neck, Volume 45, Issue 2, Page 398-408, February 2023., 2023 Abstract Background A poor evidence basis exists regarding the objective donor site morbidity associated with osseous free flap harvest. This study prospectively assessed the objective donor site morbidity associated with osseous free flap harvest for the fibula, scapula, and iliac crest (DCIA) donor sites.
Joshua Russell +7 more
wiley +1 more source
Markers for internal neoplasia in the horse
Veterinary Medicine and Science, Volume 9, Issue 1, Page 132-143, January 2023., 2023 The measurement of tumour markers in horses should be performed only in risk groups or in patients with suspicious clinical/laboratory findings (paraneoplastic syndromes). The results should be interpreted with caution as many factors (e.g., young age, pregnancy and inflammation) affect their concentration or activity.
Karolina Drozdzewska, Heidrun Gehlen
wiley +1 more source